bf/NASDAQ:CLRB_icon.jpeg

NASDAQ:CLRB

Cellectar Biosciences, Inc.

  • Stock

USD

Last Close

3.43

06/11 22:11

Market Cap

84.24M

Beta: 1.17

Volume Today

359.90K

Avg: 55.21K

PE Ratio

−1.03

PFCF: −1.36

OverviewFinancialsAPI

    Description

    Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malign...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -20-15-10-52018-05-112020-05-072022-05-102024-03-272024-10-29

    Revenue (Estimate*)

    50K100K150K200K250K300K350K2018-05-112020-05-072022-05-102024-03-272024-10-29

    *Estimate based on analyst consensus